ALNY
Alnylam Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ALNY fundamentals
During Q4 2025, Alnylam Pharmaceuticals (ALNY) reported revenue of 1.10B, a YoY change of 84.95%. Net income was 186.42M, a YoY change of 322.56%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 7.34M -60.38% | 8.71M +0.28% | 13.65M +115.86% | 17.45M +131.15% | 18.96M +158.13% | 15.93M +82.94% | 17.10M +25.24% | 37.92M +117.28% | 21.90M +15.50% | 29.91M +87.72% | 2.07M -87.90% | 21.03M -44.54% | 33.29M +52.03% | 44.71M +49.51% | 70.06M +3286.23% | 71.68M +240.80% | 99.48M +198.78% | 103.96M +132.50% | 125.85M +79.63% | 163.56M +128.18% | 177.57M +78.50% | 220.55M +112.15% | 187.63M +49.09% | 258.54M +58.07% | 213.26M +20.10% | 224.82M +1.93% | 264.31M +40.86% | 335.04M +29.59% | 319.29M +49.72% | 318.75M +41.78% | 750.53M +183.96% | 439.72M +31.25% | 494.33M +54.82% | 659.83M +107.00% | 500.92M -33.26% | 593.17M +34.90% | 594.19M +20.20% | 773.69M +17.26% | 1.25B +149.35% | 1.10B +84.95% | 3.71B -- |
Sales and Services Revenue | 7.34M -60.38% | 8.71M +0.28% | 13.65M +115.86% | 17.45M +131.15% | 18.96M +158.13% | 15.93M +82.94% | 17.10M +25.24% | 37.92M +117.28% | 21.90M +15.50% | 29.91M +87.72% | 2.07M -87.90% | 21.03M -44.54% | 33.29M +52.03% | 44.71M +49.51% | 70.06M +3286.23% | 71.68M +240.80% | 99.48M +198.78% | 103.96M +132.50% | 125.85M +79.63% | 163.56M +128.18% | 177.57M +78.50% | 220.55M +112.15% | 187.63M +49.09% | 258.54M +58.07% | 213.26M +20.10% | 224.82M +1.93% | 264.31M +40.86% | 335.04M +29.59% | 319.29M +49.72% | 318.75M +41.78% | 750.53M +183.96% | 439.72M +31.25% | 494.33M +54.82% | 659.83M +107.00% | 500.92M -33.26% | 593.17M +34.90% | 594.19M +20.20% | 773.69M +17.26% | 1.25B +149.35% | 1.10B +84.95% | 3.71B -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 137.00K -- | 1.67M -- | 3.35M -- | 4.33M -- | 5.21M +3705.11% | 12.18M +631.29% | 13.30M +297.43% | 19.93M +360.68% | 21.80M +318.13% | 23.02M +89.09% | 31.06M +133.51% | 38.76M +94.47% | 32.66M +49.85% | 37.66M +63.59% | 35.63M +14.70% | 40.81M +5.30% | 41.12M +25.88% | 51.27M +36.11% | 54.87M +54.01% | 85.37M +109.20% | 84.31M +105.05% | 85.86M +67.48% | 65.98M +20.24% | 68.67M -19.56% | 85.91M +1.89% | 102.82M +19.75% | 71.04M +7.68% | 142.95M +108.17% | 200.15M +132.99% | 267.72M +160.39% | 681.87M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.80M -- | 3.35M -- | 4.33M -- | 5.21M -- | 12.18M +575.69% | 13.30M +297.43% | 19.93M +360.68% | 21.80M +318.13% | 23.02M +89.09% | 31.06M +133.51% | 38.76M +94.47% | 32.66M +49.85% | 37.66M +63.59% | 35.63M +14.70% | 40.81M +5.30% | 41.12M +25.88% | 51.27M +36.11% | 54.87M +54.01% | 85.37M +109.20% | 84.31M +105.05% | 85.86M +67.48% | 65.98M +20.24% | 68.67M -19.56% | 85.91M +1.89% | 102.82M +19.75% | 71.04M +7.68% | 142.95M +108.17% | 200.15M +132.99% | 267.72M +160.39% | 681.87M -- |
Gross Profit | 7.34M -60.38% | 8.71M +0.28% | 13.65M +115.86% | 17.45M +131.15% | 18.96M +158.13% | 15.93M +82.94% | 17.10M +25.24% | 37.92M +117.28% | 21.90M +15.50% | 29.91M +87.72% | 1.93M -88.70% | 19.37M -48.93% | 29.95M +36.75% | 40.39M +35.05% | 64.85M +3256.52% | 59.51M +207.23% | 86.17M +187.76% | 84.03M +108.06% | 104.06M +60.46% | 140.54M +136.18% | 146.50M +70.01% | 181.80M +116.34% | 154.97M +48.93% | 220.87M +57.16% | 177.63M +21.25% | 184.01M +1.22% | 223.19M +44.02% | 283.77M +28.48% | 264.42M +48.86% | 233.38M +26.83% | 666.22M +198.50% | 353.86M +24.70% | 428.36M +62.00% | 591.15M +153.30% | 415.01M -37.71% | 490.35M +38.57% | 523.15M +22.13% | 630.74M +6.70% | 1.05B +152.73% | 829.31M +69.13% | 3.03B -- |
Operating Expenses | 117.37M +65.88% | 101.16M +23.93% | 120.33M +42.14% | 132.89M +32.80% | 125.47M +6.90% | 136.41M +34.84% | 142.90M +18.76% | 185.23M +39.39% | 169.30M +34.93% | 222.26M +62.94% | 256.49M +79.49% | 239.72M +29.42% | 218.74M +29.20% | 276.66M +24.47% | 281.15M +9.61% | 357.58M +49.16% | 296.33M +35.48% | 282.89M +2.25% | 329.25M +17.11% | 334.76M -6.38% | 332.76M +12.29% | 327.96M +15.93% | 336.65M +2.25% | 415.43M +24.10% | 324.36M -2.52% | 375.70M +14.56% | 481.23M +42.95% | 472.38M +13.71% | 414.23M +27.70% | 463.21M +23.30% | 452.35M -6.00% | 470.26M -0.45% | 471.79M +13.90% | 542.54M +17.12% | 491.92M +8.75% | 595.51M +26.63% | 505.07M +7.05% | 646.93M +19.24% | 680.89M +38.42% | 697.59M +17.14% | 2.53B -- |
Selling, General and Administrative Expenses | 21.10M +65.83% | 17.99M +23.01% | 22.39M +39.63% | 27.88M +61.81% | 38.49M +82.40% | 45.78M +154.51% | 47.64M +112.78% | 67.45M +141.98% | 72.45M +88.24% | 84.68M +84.97% | 116.55M +144.62% | 108.69M +61.13% | 89.61M +23.69% | 112.77M +33.17% | 120.35M +3.27% | 156.28M +43.78% | 126.76M +41.46% | 127.90M +13.41% | 167.47M +39.15% | 166.29M +6.41% | 146.86M +15.86% | 145.32M +13.63% | 142.07M -15.16% | 186.38M +12.08% | 154.47M +5.18% | 169.98M +16.97% | 235.86M +66.01% | 210.34M +12.86% | 183.66M +18.90% | 214.69M +26.30% | 199.18M -15.55% | 198.12M -5.81% | 210.80M +14.78% | 248.40M +15.70% | 220.99M +10.95% | 295.34M +49.07% | 239.95M +13.83% | 323.31M +30.16% | 322.08M +45.74% | 325.37M +10.17% | 1.21B -- |
Research and Development Expenses | 96.27M +65.89% | 83.17M +24.12% | 97.94M +42.73% | 105.01M +26.77% | 86.98M -9.65% | 90.63M +8.96% | 95.25M -2.74% | 117.77M +12.15% | 96.86M +11.35% | 137.58M +51.81% | 139.94M +46.92% | 131.04M +11.26% | 129.13M +33.32% | 163.89M +19.12% | 160.80M +14.90% | 201.30M +53.62% | 169.57M +31.32% | 155.00M -5.43% | 161.78M +0.61% | 168.47M -16.31% | 185.90M +9.63% | 182.63M +17.83% | 194.57M +20.27% | 229.05M +35.96% | 169.89M -8.61% | 205.71M +12.64% | 245.37M +26.11% | 262.04M +14.40% | 230.57M +35.71% | 248.53M +20.81% | 253.18M +3.18% | 272.14M +3.86% | 261.00M +13.20% | 294.14M +18.35% | 270.93M +7.01% | 300.17M +10.30% | 265.12M +1.58% | 323.62M +10.02% | 358.81M +32.44% | 372.22M +24.00% | 1.32B -- |
Operating Income | -110.03M -110.69% | -92.45M -26.74% | -106.68M -36.19% | -115.43M -24.78% | -106.51M +3.20% | -120.47M -30.31% | -125.80M -17.93% | -147.30M -27.61% | -147.41M -38.39% | -192.35M -59.66% | -254.56M -102.35% | -220.36M -49.59% | -188.79M -28.07% | -236.27M -22.83% | -216.30M +15.03% | -298.07M -35.27% | -210.16M -11.32% | -198.86M +15.83% | -225.20M -4.11% | -194.22M +34.84% | -186.25M +11.37% | -146.16M +26.50% | -181.68M +19.33% | -194.56M -0.17% | -146.73M +21.22% | -191.69M -31.15% | -258.04M -42.03% | -188.61M +3.06% | -149.81M -2.10% | -229.83M -19.90% | 213.87M +182.88% | -116.40M +38.28% | -43.44M +71.01% | 48.61M +121.15% | -76.91M -135.96% | -105.16M +9.66% | 18.08M +141.62% | -16.20M -133.32% | 367.98M +578.49% | 131.72M +225.26% | 501.58M -- |
Non-Operating Income (Loss) | 7.05M +595.66% | 2.32M +45.79% | 2.60M +69.38% | 2.50M +39.53% | -779.00K -111.04% | 2.05M -11.50% | 2.86M +9.90% | 5.08M +103.12% | 6.13M +886.78% | 28.87M +1305.70% | 9.72M +239.54% | 9.28M +82.74% | 7.57M +23.48% | 17.75M -38.52% | 7.37M -24.18% | 21.49M +131.67% | 28.51M +276.74% | 20.96M +18.06% | -27.25M -469.78% | -49.38M -329.77% | -13.02M -145.67% | -42.17M -301.24% | -22.56M +17.22% | -65.74M -33.14% | -92.62M -611.34% | -82.99M -96.79% | -147.90M -555.63% | -18.41M +72.00% | -22.55M +75.65% | -44.38M +46.52% | -63.13M +57.32% | -21.28M -15.62% | -20.15M +10.65% | -59.78M -34.71% | -31.76M +49.69% | -88.80M -317.23% | -59.67M -196.11% | -19.16M +67.95% | -129.01M -306.24% | 29.42M +133.13% | -178.43M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.43M -- | 18.69M -- | -61.27M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 9.42M -- | 0 -- | -9.42M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.59M -- | 3.19M -- | 19.66M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 5.24M -- | 229.00K +948.15% | 401.00K +656.94% | 300.00K +71.43% | -2.91M -155.47% | 0 -100.00% | -433.00K -207.98% | 841.00K +180.33% | 335.00K +111.52% | 22.77M -- | 2.92M +775.52% | -1.29M -253.98% | 43.00K -87.16% | -453.00K -101.99% | -2.52M -186.12% | 23.66M +1926.95% | 23.03M +53462.79% | 45.04M +10042.38% | -594.00K +76.42% | -10.14M -142.87% | 19.04M -17.32% | -140.00K -100.31% | -4.39M -638.89% | 12.20M +220.26% | -51.27M -369.24% | -42.28M -30097.86% | -114.64M -2511.96% | -2.57M -121.08% | -12.26M +76.10% | -35.42M +16.22% | -57.66M +49.70% | -20.35M -691.56% | -14.54M -18.68% | -55.70M -57.28% | -29.53M +48.79% | -80.85M -297.26% | -49.70M -241.72% | -6.40M +88.51% | -113.30M -283.69% | 132.13M +263.43% | -37.27M -- |
Net Interest Expense | -1.81M -78.80% | -2.09M -29.22% | -2.20M -36.89% | -2.20M -36.08% | -2.13M -17.37% | -2.05M +1.82% | -3.30M -49.55% | -4.24M -92.59% | -5.79M -172.27% | -6.10M -197.03% | -6.80M -106.19% | -10.57M -149.61% | -7.53M -29.88% | -8.78M -43.93% | -9.89M -45.51% | -7.25M +31.39% | -5.48M +27.18% | 24.08M +374.26% | 26.66M +369.58% | 39.23M +640.93% | 32.06M +685.13% | 33.01M +37.06% | 40.05M +50.23% | 36.32M -7.42% | 41.35M +28.96% | 40.71M +23.34% | 33.26M -16.94% | 15.84M -56.40% | 10.30M -75.09% | 8.96M -77.99% | 5.47M -83.56% | 932.00K -94.11% | 5.61M -45.55% | 4.08M -54.51% | 2.23M -59.22% | 7.95M +753.22% | 9.97M +77.84% | 12.76M +213.05% | 15.72M +604.80% | 102.71M +1191.59% | 141.16M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 27.25M -- | 28.73M -- | 28.52M -- | 32.52M -- | 33.42M +22.64% | 40.27M +40.18% | 36.82M +29.10% | 42.36M +30.28% | 42.61M +27.51% | 41.08M +2.01% | 29.91M -18.75% | 28.95M -31.65% | 30.04M -29.51% | 30.89M -24.81% | 31.34M +4.76% | 35.25M +21.75% | 33.26M +10.73% | 34.38M +11.27% | 38.97M +24.36% | 38.65M +9.62% | 40.25M +21.01% | 44.40M +29.15% | 129.34M +231.88% | 252.63M -- |
Interest Income | 1.81M +78.80% | 2.09M +29.22% | 2.20M +36.89% | 2.20M +36.08% | 2.13M +17.37% | 2.05M -1.82% | 3.30M +49.55% | 4.24M +92.59% | 5.79M +172.27% | 6.10M +197.03% | 6.80M +106.19% | 10.57M +149.61% | 7.53M +29.88% | 8.78M +43.93% | 9.89M +45.51% | 7.25M -31.39% | 5.48M -27.18% | 3.17M -63.96% | 2.07M -79.05% | -10.72M -247.76% | 450.00K -91.79% | 409.00K -87.08% | 225.00K -89.14% | 495.00K +104.62% | 1.01M +124.89% | 1.90M +364.30% | 7.82M +3375.56% | 14.08M +2743.84% | 18.66M +1743.38% | 21.07M +1009.79% | 25.43M +225.13% | 30.41M +116.00% | 29.64M +58.91% | 29.18M +38.47% | 32.15M +26.43% | 31.02M +2.02% | 28.67M -3.28% | 27.49M -5.81% | 28.68M -10.78% | 26.63M -14.15% | 111.47M -- |
Pretax Income From Continuing Operations | -102.97M -101.09% | -90.13M -26.32% | -104.07M -35.52% | -112.93M -24.48% | -107.29M -4.19% | -118.42M -31.39% | -122.94M -18.13% | -142.23M -25.94% | -141.28M -31.68% | -163.48M -38.05% | -244.84M -99.16% | -211.08M -48.41% | -181.22M -28.27% | -218.52M -33.67% | -208.93M +14.67% | -276.58M -31.03% | -181.65M -0.24% | -177.90M +18.59% | -252.45M -20.83% | -243.60M +11.93% | -199.28M -9.71% | -188.33M -5.86% | -204.24M +19.10% | -260.30M -6.86% | -239.36M -20.11% | -274.67M -45.85% | -405.94M -98.76% | -207.02M +20.47% | -172.36M +27.99% | -274.21M +0.17% | 150.74M +137.13% | -137.69M +33.49% | -63.59M +63.11% | -11.17M +95.93% | -108.66M -172.09% | -193.96M -40.87% | -41.60M +34.58% | -35.36M -216.63% | 238.97M +319.92% | 161.14M +183.08% | 323.15M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -62.00K -- | 79.00K -- | 445.00K -- | 361.00K -- | 695.00K +1220.97% | 960.00K +1115.19% | -394.00K -188.54% | -398.00K -210.25% | 575.00K -17.27% | 1.33M +38.13% | 839.00K +312.94% | -59.00K +85.18% | 1.02M +76.70% | 1.23M -7.39% | 278.00K -66.87% | -1.84M -3022.03% | 985.00K -3.05% | 2.73M +122.23% | -23.00K -108.27% | 472.00K +125.62% | 1.74M +76.55% | 1.81M -33.49% | 2.99M +13091.30% | 183.00K -61.23% | 2.35M +35.02% | 5.72M +215.26% | 2.91M -2.71% | -110.19M -60315.85% | 15.88M +576.45% | 30.92M +440.35% | -12.12M -516.75% | -25.28M +77.06% | 9.40M -- |
Current Income Tax | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.61M -- | -- -- | -- -- | -- -- | 2.84M +76.16% | -- -- | -- -- | -- -- | 5.90M +107.82% | -- -- | -- -- | -- -- | 3.45M -41.56% | -- -- | -- -- | -- -- | 5.60M +62.34% | -- -- | -- -- | -- -- | 7.44M +32.92% | -- -- | -- -- | -- -- | 7.54M +1.43% | -- -- | -- -- | -- -- | 11.60M +53.80% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -788.00K -- | -- -- | -- -- | -- -- | -1.98M -150.63% | -- -- | -- -- | -- -- | -3.22M -62.89% | -- -- | -- -- | -- -- | -2.77M +13.99% | -- -- | -- -- | -- -- | -1.43M +48.21% | -- -- | -- -- | -- -- | -713.00K +50.24% | -- -- | -- -- | -- -- | -106.76M -14873.63% | -- -- | -- -- | -- -- | -2.20M +97.94% | -- -- |
Net Income | -102.97M -102.80% | -90.13M -25.56% | -104.07M -35.52% | -112.93M -24.48% | -107.29M -4.19% | -118.42M -31.39% | -122.94M -18.13% | -142.23M -25.94% | -141.21M -31.62% | -163.56M -38.12% | -245.28M -99.52% | -211.44M -48.66% | -181.91M -28.82% | -219.48M -34.19% | -208.53M +14.98% | -276.19M -30.62% | -182.22M -0.17% | -179.23M +18.34% | -253.29M -21.46% | -243.54M +11.82% | -200.29M -9.92% | -189.56M -5.76% | -204.51M +19.26% | -258.46M -6.13% | -240.34M -20.00% | -277.40M -46.34% | -405.92M -98.48% | -207.49M +19.72% | -174.10M +27.56% | -276.02M +0.50% | 147.75M +136.40% | -137.87M +33.55% | -65.94M +62.13% | -16.89M +93.88% | -111.57M -175.51% | -83.76M +39.24% | -57.48M +12.82% | -66.28M -292.43% | 251.08M +325.05% | 186.42M +322.56% | 313.75M -- |
Net Income Attributable to Owners of the Company | -102.97M -102.80% | -90.13M -25.56% | -104.07M -35.52% | -112.93M -24.48% | -107.29M -4.19% | -118.42M -31.39% | -122.94M -18.13% | -142.23M -25.94% | -141.21M -31.62% | -163.56M -38.12% | -245.28M -99.52% | -211.44M -48.66% | -181.91M -28.82% | -219.48M -34.19% | -208.53M +14.98% | -276.19M -30.62% | -182.22M -0.17% | -179.23M +18.34% | -253.29M -21.46% | -243.54M +11.82% | -200.29M -9.92% | -189.56M -5.76% | -204.51M +19.26% | -258.46M -6.13% | -240.34M -20.00% | -277.40M -46.34% | -405.92M -98.48% | -207.49M +19.72% | -174.10M +27.56% | -276.02M +0.50% | 147.75M +136.40% | -137.87M +33.55% | -65.94M +62.13% | -16.89M +93.88% | -111.57M -175.51% | -83.76M +39.24% | -57.48M +12.82% | -66.28M -292.43% | 251.08M +325.05% | 186.42M +322.56% | 313.75M -- |
Net Income Attributable to Common Stockholders | -102.97M -102.80% | -90.13M -25.56% | -104.07M -35.52% | -112.93M -24.48% | -107.29M -4.19% | -118.42M -31.39% | -122.94M -18.13% | -142.23M -25.94% | -141.21M -31.62% | -163.56M -38.12% | -245.28M -99.52% | -211.44M -48.66% | -181.91M -28.82% | -219.48M -34.19% | -208.53M +14.98% | -276.19M -30.62% | -182.22M -0.17% | -179.23M +18.34% | -253.29M -21.46% | -243.54M +11.82% | -200.29M -9.92% | -189.56M -5.76% | -204.51M +19.26% | -258.46M -6.13% | -240.34M -20.00% | -277.40M -46.34% | -405.92M -98.48% | -207.49M +19.72% | -174.10M +27.56% | -276.02M +0.50% | 147.75M +136.40% | -137.87M +33.55% | -65.94M +62.13% | -16.89M +93.88% | -111.57M -175.51% | -83.76M +39.24% | -57.48M +12.82% | -66.28M -292.43% | 251.08M +325.05% | 186.42M +322.56% | 313.75M -- |
Other Comprehensive Income | -13.38M -469.41% | -19.29M +42.64% | 518.00K +101.99% | -5.66M -148.87% | -387.00K +97.11% | -131.00K +99.32% | 218.00K -57.92% | -692.00K +87.78% | -420.00K -8.53% | 1.05M +898.47% | 415.00K +90.37% | 179.00K +125.87% | 360.00K +185.71% | -2.98M -384.70% | 1.46M +251.81% | -2.15M -1299.44% | 4.46M +1138.61% | -1.15M +61.28% | -3.98M -372.67% | -6.43M -199.44% | 6.91M +54.86% | 636.00K +155.16% | 1.85M +146.50% | 971.00K +115.10% | -4.81M -169.60% | -4.16M -753.93% | -1.56M -184.22% | -871.00K -189.70% | 5.53M +215.06% | 2.04M +149.15% | 4.74M +404.11% | 8.96M +1129.16% | -3.61M -165.33% | -7.65M -474.22% | 9.81M +106.94% | -9.69M -208.12% | -3.00M +16.99% | 7.57M +198.90% | 8.18M -16.65% | 1.68M +117.31% | 14.42M -- |
Total Comprehensive Income | -116.35M -146.75% | -109.41M -3.80% | -103.55M -0.76% | -118.60M -49.87% | -107.68M +7.46% | -118.55M -8.35% | -122.72M -18.51% | -142.92M -20.51% | -141.63M -31.54% | -162.51M -37.08% | -244.87M -99.53% | -211.26M -47.82% | -181.56M -28.19% | -222.46M -36.89% | -207.07M +15.43% | -278.33M -31.75% | -177.76M +2.09% | -180.38M +18.91% | -257.27M -24.24% | -249.97M +10.19% | -193.39M -8.79% | -188.92M -4.73% | -202.66M +21.23% | -257.49M -3.01% | -245.15M -26.77% | -281.56M -49.03% | -407.48M -101.06% | -208.36M +19.08% | -168.57M +31.24% | -273.98M +2.69% | 152.49M +137.42% | -128.91M +38.13% | -69.55M +58.74% | -24.54M +91.04% | -101.76M -166.73% | -93.45M +27.50% | -60.48M +13.04% | -58.71M -139.27% | 259.26M +354.78% | 188.10M +301.27% | 328.17M -- |
Total Comprehensive Income Attributable to Owners of the Company | -116.35M -146.75% | -109.41M -3.80% | -103.55M -0.76% | -118.60M -49.87% | -107.68M +7.46% | -118.55M -8.35% | -122.72M -18.51% | -142.92M -20.51% | -141.63M -31.54% | -162.51M -37.08% | -244.87M -99.53% | -211.26M -47.82% | -181.56M -28.19% | -222.46M -36.89% | -207.07M +15.43% | -278.33M -31.75% | -177.76M +2.09% | -180.38M +18.91% | -257.27M -24.24% | -249.97M +10.19% | -193.39M -8.79% | -188.92M -4.73% | -202.66M +21.23% | -257.49M -3.01% | -245.15M -26.77% | -281.56M -49.03% | -407.48M -101.06% | -208.36M +19.08% | -168.57M +31.24% | -273.98M +2.69% | 152.49M +137.42% | -128.91M +38.13% | -69.55M +58.74% | -24.54M +91.04% | -101.76M -166.73% | -93.45M +27.50% | -60.48M +13.04% | -58.71M -139.27% | 259.26M +354.78% | 188.10M +301.27% | 328.17M -- |
Basic EPS | -1.21 -95.16% | -1.05 -23.53% | -1.21 -32.97% | -1.31 -22.43% | -1.25 -3.31% | -1.34 -27.62% | -1.34 -10.74% | -1.43 -9.16% | -1.41 -12.80% | -1.63 -21.64% | -2.43 -81.34% | -2.09 -46.15% | -1.73 -22.70% | -2.02 -23.93% | -1.92 +20.99% | -2.46 -17.70% | -1.62 +6.36% | -1.56 +22.77% | -2.18 -13.54% | -2.09 +15.04% | -1.71 -5.56% | -1.61 -3.21% | -1.72 +21.10% | -2.15 -2.87% | -2 -16.96% | -2.29 -42.24% | -3.32 -93.02% | -1.67 +22.33% | -1.4 +30.00% | -2.21 +3.49% | 1.18 +135.54% | -1.1 +34.13% | -0.52 +62.86% | -0.13 +94.12% | -0.87 -173.73% | -0.65 +40.91% | -0.44 +15.38% | -0.51 -292.31% | 1.91 +319.54% | 1.41 +316.92% | 2.37 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.73 -- | -2.02 -- | -1.92 -- | -- -- | -1.62 +6.36% | -1.56 +22.77% | -2.18 -13.54% | -- -- | -1.71 -5.56% | -1.61 -3.21% | -1.72 +21.10% | -- -- | -2 -16.96% | -2.29 -42.24% | -3.32 -93.02% | -- -- | -1.4 +30.00% | -2.21 +3.49% | 1.18 +135.54% | -- -- | -0.52 +62.86% | -0.13 +94.12% | -0.87 -173.73% | -- -- | -0.44 +15.38% | -0.51 -292.31% | 1.91 +319.54% | -- -- | -- -- |
Diluted EPS | -1.21 -95.16% | -1.05 -23.53% | -1.21 -32.97% | -- -- | -1.25 -3.31% | -- -- | -1.34 -10.74% | -- -- | -- -- | -1.63 -- | -2.43 -81.34% | -- -- | -1.73 -- | -2.02 -23.93% | -1.92 +20.99% | -- -- | -1.62 +6.36% | -1.56 +22.77% | -2.18 -13.54% | -- -- | -1.71 -5.56% | -1.61 -3.21% | -1.72 +21.10% | -- -- | -2 -16.96% | -2.29 -42.24% | -3.32 -93.02% | -- -- | -1.4 +30.00% | -2.21 +3.49% | 1.15 +134.64% | -- -- | -0.52 +62.86% | -0.13 +94.12% | -0.87 -175.65% | -- -- | -0.44 +15.38% | -0.51 -292.31% | 1.84 +311.49% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.73 -- | -2.02 -- | -1.92 -- | -- -- | -1.62 +6.36% | -1.56 +22.77% | -2.18 -13.54% | -- -- | -1.71 -5.56% | -1.61 -3.21% | -1.72 +21.10% | -- -- | -2 -16.96% | -2.29 -42.24% | -3.32 -93.02% | -- -- | -1.4 +30.00% | -2.21 +3.49% | 1.15 +134.64% | -- -- | -0.52 +62.86% | -0.13 +94.12% | -0.87 -175.65% | -- -- | -0.44 +15.38% | -0.51 -292.31% | 1.84 +311.49% | -- -- | -- -- |
You can ask Aime
What does Alnylam Pharmaceuticals do and what are its main business segments?What were the key takeaways from Alnylam Pharmaceuticals's earnings call?What factors drove the changes in Alnylam Pharmaceuticals's revenue and profit?What is Alnylam Pharmaceuticals's latest dividend and current dividend yield?What is Alnylam Pharmaceuticals's gross profit margin?What is the revenue and EPS growth rate for Alnylam Pharmaceuticals year over year?What were the key takeaways from Alnylam Pharmaceuticals’s earnings call?What guidance did Alnylam Pharmaceuticals's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
